A Prevention Prescription for Hong Kong
Roche Diagnostics Hong Kong general manager Ronald Lo is pushing the city beyond reactive medicine towards a prevention-led system powered by automation, AI and empowered patients. For Ronald Lo, diagnostics are about time. Time gained through early detection. Time saved by avoiding unnecessary treatment. Time extended for patients who might otherwise run out of options. Since becoming general…
Roche Diagnostics Hong Kong's general manager Ronald Lo is spearheading a push towards a prevention-focused healthcare system in the city. This shift aims to move away from a treatment-centric model and embrace automation, artificial intelligence (AI), and empowered patients. Lo, who joined the company in 2022, believes Hong Kong has the urgency and resources to transition to a prevention-led healthcare ecosystem.
Diagnostics is seen as a central component in managing healthcare costs, improving outcomes, and reshaping patient journeys. Lo emphasizes the importance of early diagnosis, as late detection can lead to irreversible progression and significant financial, emotional, and quality of life impacts for patients and families. He provides examples of how diagnostics can improve patient care, such as in heart failure, where earlier cardiomarker testing allows for quicker hospital discharge and lower costs, and in oncology, where molecular testing can guide targeted therapies and avoid ineffective treatments.
Timely diabetes testing can alter the disease's long-term trajectory. Lo notes that prevention can sometimes mean avoiding treatment altogether by simply changing a patient's lifestyle. The Covid-19 pandemic accelerated public awareness of diagnostics, as the crisis highlighted the importance of early detection and testing. The Hong Kong government's Primary Healthcare Blueprint and Chronic Disease Co-Care Programme further demonstrate a growing recognition of the value of early screening and community-based care.
Roche's diagnostic technology, such as automated systems processing multiple tests per hour and introducing mass spectrometry into routine workflows, has been instrumental in this shift. However, Lo stresses that technology alone is not sufficient; data and artificial intelligence are crucial in enhancing predictive power. He envisions a future where diagnostics extend beyond hospital walls, empowering patients with AI-enabled systems for continuous glucose monitoring and informed decision-making.
Lo believes that an empowered patient is a strength, as increased knowledge enables better self-care. As a leader, Lo emphasizes the importance of personal integrity and purpose in guiding both oneself and one's team.
Written by urgent.news from SCMP Business's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.